Valuation: Biogen Inc.

Market Cap 30.91B 26.85B 24.94B 23B 43.32B 2,951B 44.1B 295B 116B 1,466B 116B 114B 4,929B P/E 2026 *
31.6x
P/E 2027 * 17.4x
Enterprise Value 36.16B 31.41B 29.17B 26.9B 50.67B 3,452B 51.59B 345B 135B 1,715B 136B 133B 5,766B EV / Sales 2026 *
3.48x
EV / Sales 2027 * 3.13x
Free-Float
85.96%
Yield 2026 *
-
Yield 2027 * -
1 day-1.47%
1 week+3.04%
Current month-4.33%
1 month-4.33%
3 months+9.21%
6 months+14.91%
Current year+17.46%
1 week 199.4
Extreme 199.4
218.59
1 month 186.02
Extreme 186.025
219.02
Current year 160.36
Extreme 160.3645
219.72
1 year 124.56
Extreme 124.5561
219.72
3 years 110.04
Extreme 110.035
278.95
5 years 110.04
Extreme 110.035
351.86
10 years 110.04
Extreme 110.035
468.55
Manager TitleAgeSince
Chief Executive Officer 66 14/11/2022
Director of Finance/CFO 60 01/03/2025
Chief Tech/Sci/R&D Officer - 01/01/2021
Director TitleAgeSince
Director/Board Member 69 23/03/2010
Director/Board Member 77 01/01/2010
Director/Board Member 72 19/06/2019
Date Insider Type Main position Quantity % Market Cap.
9/6/26 Free

Director

1,505 0.0010%
13/2/26 Free

Head of Human Resources

8,025 0.0055%
13/2/26 Free

Executive/Senior Manager

10,560 0.0072%
Change 5-day change 1-year change 3-year change Capi.($)
-1.47%+3.04%+63.23%-23.49% 30.91B
+3.24%+9.98%+29.28%-3.36% 70.75B
-13.51%-10.70%+17.04%+169.50% 54.35B
+3.25%+52.70%+52.70%+52.70% 47.19B
-0.11%+8.47%-52.97%-52.04% 42.48B
-3.55%+5.07%+58.10%+92.42% 25.76B
+3.82%-0.70%+76.11%-51.88% 21.62B
-1.78%-4.50%-11.86%+140.71% 19.91B
-2.48%-2.00%+78.16%+132.15% 16.33B
-0.13%+3.10%+69.03%+129.42% 16.9B
Average -1.28%+2.90%+37.88%+58.61% 34.62B
Weighted average by Cap. -1.41%+3.87%+30.44%+48.90%

Financials

2026 *2027 *
Net sales 10.38B 9.02B 8.37B 7.72B 14.54B 991B 14.81B 99.12B 38.81B 492B 38.98B 38.13B 1,655B 10.54B 9.16B 8.5B 7.84B 14.77B 1,006B 15.04B 101B 39.41B 500B 39.59B 38.72B 1,681B
Net income 1.04B 900M 835M 770M 1.45B 98.87B 1.48B 9.89B 3.87B 49.11B 3.89B 3.8B 165B 1.97B 1.71B 1.59B 1.47B 2.77B 188B 2.82B 18.85B 7.38B 93.61B 7.41B 7.25B 315B
Net Debt 5.25B 4.56B 4.23B 3.9B 7.35B 501B 7.49B 50.11B 19.62B 249B 19.71B 19.28B 837B 2.04B 1.77B 1.64B 1.51B 2.85B 194B 2.9B 19.43B 7.61B 96.49B 7.64B 7.48B 324B
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
31/07/26 US$206.61 -1.25% 411,798
29/07/26 US$209.23 +1.76% 2,400,174
28/07/26 US$205.61 +2.73% 1,832,179
27/07/26 US$200.14 -1.01% 762,581
24/07/26 US$202.19 +0.78% 596,372
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
36
Last Close Price
209.23USD
Average target price
232.93USD
Spread / Average Target
+11.33%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIIB Stock